Reduced type 2 epithelial-mesenchymal transition serves as a risk factor for the progression from endometriosis to endometriosis-associated ovarian cancer
Reduced type 2 epithelial-mesenchymal transition in endometriosis lesions is associated with progression to endometriosis-associated ovarian cancer, potentially regulated by C7 fibroblasts.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study investigated epithelial–mesenchymal transition (EMT) changes during the malignant transformation of endometriosis (EMS) into endometriosis-associated ovarian cancer (EAOC) by integrating public transcriptomic data for EAOC with single-cell data for EMS. The authors reported that overall EMT levels in EAOC were significantly lower than in EMS, largely driven by a reduction in type 2 EMT linked to fibrosis, and they used immunohistochemistry and Masson staining to validate EMT and fibrosis differences. They also found that C7 fibroblasts were abundant in EMS lesions but reduced in EAOC, suggesting a regulatory role for these fibroblasts in EMT during progression; a key caveat is that the analysis relies on retrieved public datasets plus validation staining rather than direct longitudinal sampling. This paper is centrally about endometriosis-associated ovarian cancer—specifically comparing EMT subtype shifts and C7 fibroblast abundance during progression from endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
4,966 characters
· extracted from
oa-html
· 2 sections
· click to expand
Abstract
Acknowledgements
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- pubmed
- last seen: 2026-05-24T00:30:04.876325+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
Courtesy of the U.S. National Library of Medicine